These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 718981)

  • 1. Purification and properties of porcine platelet aggregating factor.
    Marcus DL; Johnson AJ; Finlay TH
    Biochim Biophys Acta; 1978 Nov; 537(1):44-61. PubMed ID: 718981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of porcine and human ristocetin-Willebrand factor.
    Olson JD; Brockway WJ; Fass DN; Bowie EJ; Mann KG
    J Lab Clin Med; 1977 Jun; 89(6):1278-94. PubMed ID: 405441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.
    Griggs TR; Cooper HA; Webster WP; Wagner RH; Brinkhous KM
    Proc Natl Acad Sci U S A; 1973 Oct; 70(10):2814-8. PubMed ID: 4542779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and properties of bovine factor VIII (antihemophilic factor).
    Vehar GA; Davie EW
    Biochemistry; 1980 Feb; 19(3):401-10. PubMed ID: 7356933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of thrombin on the platelet-aggregating activity of human factor VIII. A study with insolubilized thrombin.
    Vukovich T; Koller E; Doleschel W
    Thromb Haemost; 1979 Oct; 42(3):832-7. PubMed ID: 505400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.
    Allain JP; Cooper HA; Wagner RH; Brinkhous KM
    J Lab Clin Med; 1975 Feb; 85(2):318-28. PubMed ID: 234499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.
    Harris RB; Newman J; Johnson AJ
    Biochim Biophys Acta; 1981 May; 668(3):456-70. PubMed ID: 6786356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of porcine von Willebrand factor (platelet aggregating factor) with human platelets.
    Finlay TH; Marcus DL; Kowalski S; Silber P
    Biochim Biophys Acta; 1981 Jan; 672(1):79-88. PubMed ID: 6260227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VIII and human platelet aggregation. III. Further studies on aggregation of humna platelets by neuraminidase-treated human factor VIII.
    Vermylen J; Bottecchia D; Szpilman H
    Br J Haematol; 1976 Oct; 34(2):321-30. PubMed ID: 974043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isolation and some properties of factor VIII (antihemophilic factor)].
    Bykowska K; Lopaciuk S; Michalski R
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):283-92. PubMed ID: 998139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human platelet factor 4: Purification and characterization by affinity chromatography. Purification of human platelet factor 4.
    Levine SP; Wohl H
    J Biol Chem; 1976 Jan; 251(2):324-8. PubMed ID: 812871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Purification and some properties of platelet aggregating protein (PAP) from the plasma of a patient with thrombotic thrombocytopenic purpura].
    Chen SH
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):382-4, 28. PubMed ID: 2598093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII and human platelet aggregation. I. Evience that the platelet aggregating activity of bovine factor VIII is a property of its 'carrier protein' subunit.
    Bottecchia D; Vermylen J
    Br J Haematol; 1976 Oct; 34(2):303-11. PubMed ID: 987796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA; Andersen JC; Pizzo SV; McKee PA
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of platelet aggregating activity from tumor cells: copurification with procoagulant activity.
    Cavanaugh PG; Sloane BF; Bajkowski AS; Taylor JD; Honn KV
    Thromb Res; 1985 Jan; 37(2):309-26. PubMed ID: 3975874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification of two heparin-binding proteins from porcine platelets and their homology with human secreted platelet proteins.
    Rucinski B; Poggi A; James P; Holt JC; Niewiarowski S
    Blood; 1983 Jun; 61(6):1072-80. PubMed ID: 6839017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and insolubilisation of human F VIII by affinity chromatography.
    Madaras F; Bell WR; Castaldi PA
    Haemostasis; 1978; 7(6):321-31. PubMed ID: 720954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. II. Further purification with thiol-disulfide interchange chromatography and additional evidence for disulfide bonds susceptible to limited reduction.
    Harris RB; Johnson AJ; Hodgins LT
    Biochim Biophys Acta; 1981 May; 668(3):471-80. PubMed ID: 6786357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.